Soffer Gad
EVP &Chief Strategy Officer | Chief Operating Officer
1 company
Soffer Gad is an EVP &Chief Strategy Officer at Atara Biotherapeutics, Inc.. Recent SEC Form 4 filings include 0 buys and 16 sells.
Estimated insider holdings value: $2.6M based on current market prices.
Holdings by Company
ATRASep 22, 2018
Current Shares244.0K
Value$2.57M
Net Activity-110,952
Bought: 0Sold: 111.0K
Transaction History
Showing 10 filings
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Nov 17, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP &Chief Strategy Officer | Sale+OE | 7,000 | $15.00 | $105,000.00 | -2.7% | |
| Aug 16, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP &Chief Strategy Officer | Sale+OE | 9,464 | $14.88 | $140,801.92 | -1.8% | |
| May 16, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP &Chief Strategy Officer | Sale+OE | 12,674 | $15.16 | $192,098.06 | -2.4% | |
| Mar 10, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP &Chief Strategy Officer | Sell | 2,500 | $20.00 | $50,000.00 | -0.9% | |
| Feb 16, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP &Chief Strategy Officer | Sale+OE | 14,273 | $15.42 | $220,144.26 | -2.6% | |
| Feb 10, 2017 | ATRA Atara Biotherapeutics, Inc. | EVP &Chief Strategy Officer | Sell | 6,274 | $15.47 | $97,029.08 | -1.1% | |
| Nov 17, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Operating Officer | Sell | 1,480 | $18.41 | $27,246.80 | -0.6% | |
| Nov 16, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Operating Officer | Sale+OE | 16,718 | $20.00 | $334,420.82 | -3.5% | |
| Aug 16, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,356 | $22.41 | $120,039.64 | -1.8% | |
| May 17, 2016 | ATRA Atara Biotherapeutics, Inc. | Chief Operating Officer | Sale+OE | 5,427 | $15.91 | $86,343.57 | -3.8% |
Page 1Next →